Anil Kumar, Ph.D

Business Development Manager at Kactus Bio

Speaker

Anil Kumar holds a Ph.D. in Protein Engineering from NTU, Singapore, and brings over a decade of experience in biopharmaceutical R&D, with expertise in protein design and therapeutic innovation for immune-oncology and autoimmune indications.

Prior to joining KACTUS Bio, Anil served as Director of Antibody Discovery and Protein Engineering at ImmunOs Therapeutics in Switzerland, where he spearheaded the development of next-generation HLA and monoclonal antibody based therapeutics. His team successfully advanced multiple immune-oncology programs, including the company’s lead candidate IOS-1002 into Phase 1 clinical development for solid tumors.

At KACTUS Bio, Anil blends his deep scientific expertise with strategic business development, aiming towards building partnerships and delivering high-quality recombinant proteins and GMP-grade enzymes to accelerate drug discovery and development efforts.